norfloxacin has been researched along with Pneumonia in 5 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixteen patients, 14 with an infection of the lower respiratory tract and two with cholangitis, were treated with pefloxacin 400 mg bid or tid." | 3.67 | Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units. ( Lauwers, S; Naessens, A; Pierard, D; Vincken, W, 1986) |
| "pneumoniae was 31." | 1.72 | Extended-spectrum beta-lactamases among Klebsiella pneumoniae from Iraqi patients with community-acquired pneumonia. ( Akrami, S; Alkhudhairy, MK; Benyagoub, E; Raouf, FEA; Saki, M, 2022) |
| "Pefloxacin was used to treat nosocomial pulmonary infections in 46 mechanically ventilated patients." | 1.27 | Pefloxacin in the treatment of nosocomial lower respiratory tract infections in intensive care patients. ( Fourrier, F; Gouin, F; Junginger, W; Martin, C; Prieur, BL, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raouf, FEA | 1 |
| Benyagoub, E | 1 |
| Alkhudhairy, MK | 1 |
| Akrami, S | 1 |
| Saki, M | 1 |
| Hirai, K | 1 |
| Aoyama, H | 1 |
| Hosaka, M | 1 |
| Oomori, Y | 1 |
| Niwata, Y | 1 |
| Suzue, S | 1 |
| Irikura, T | 1 |
| Martin, C | 1 |
| Gouin, F | 1 |
| Fourrier, F | 1 |
| Junginger, W | 1 |
| Prieur, BL | 1 |
| Lauwers, S | 1 |
| Vincken, W | 1 |
| Naessens, A | 1 |
| Pierard, D | 1 |
| Chomarat, M | 1 |
| Joulie, V | 1 |
| Fournier, G | 1 |
| Bouletreau, P | 1 |
| Flandrois, JP | 1 |
5 other studies available for norfloxacin and Pneumonia
| Article | Year |
|---|---|
Extended-spectrum beta-lactamases among Klebsiella pneumoniae from Iraqi patients with community-acquired pneumonia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Humans; Imipenem; Iraq; Klebsiella Infections; Klebsiella pn | 2022 |
In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Resistance, Micr | 1986 |
Pefloxacin in the treatment of nosocomial lower respiratory tract infections in intensive care patients.
Topics: Adolescent; Adult; Aged; Bronchopneumonia; Cross Infection; Female; Humans; Lung Abscess; Male; Midd | 1988 |
Efficacy and safety of pefloxacin in the treatment of severe infections in patients hospitalized in intensive care units.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bronchopneumonia; Ch | 1986 |
[Pharmacokinetic study of pefloxacin in 37 hospital patients under resuscitation].
Topics: Humans; Intensive Care Units; Kinetics; Meningitis; Norfloxacin; Pefloxacin; Pneumonia; Risk; Sepsis | 1985 |